Mendelian non-syndromic obesity
- PMID: 31577261
- PMCID: PMC7233639
- DOI: 10.23750/abm.v90i10-S.8766
Mendelian non-syndromic obesity
Abstract
Obesity is highly heritable and arises from the interplay of many genes and environmental factors. It can be defined as the result of prolonged imbalance between calorie intake and energy utilization. About 5% of cases of non-syndromic obesity are monogenic (Mendelian obesity). The amount of adipose tissue in the body is mainly regulated by leptin, a hormone produced by adipocytes, and Mendelian obesity is mainly caused by mutations that disrupt the leptin/melanocortin pathway. In this article, we summarize the genes involved in genetic obesity and the test we use for genetic analysis.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article
References
-
- World Health Organ Tech Rep Ser. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. 2000;894:1–253. - PubMed
-
- Chen B, Gagnon M, Shahangian S, et al. Good laboratoty practices for molecular genetic testing for heritable diseases and conditions. MMWR Recomm Rep. 2009;58:1–29. - PubMed
-
- Paolacci S, Borrelli A, Stuppia L, et al. Mendelian obesity, molecular pathways and pharmacological therapies: a review. Eur Rev Med Pharmacol Sci. 2019;23:1357–1378. - PubMed
-
- Paolini B, Maltese PE, Del Ciondolo I, et al. Prevalence of mutations in LEP, LEPR, and MC4R genes in individuals with severe obesity. Genet Mol Res. 2016;15 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
